"Attending #PCICS2025? Visit us at table 33 to learn about ProNephro AKI (NGAL) – the first test for AKI risk assessment in ICU patients 3 months to 22 years.
#NGAL4kids #PedsICU

Attending #ESPNIC2025? Join us for lunch and learn about NGAL for managing fluids in your critically ill AKI patients, or visit us at stand 23 in the exhibit hall. #NGAL4kids @espnic.bsky.social

Lunch Symposium
🗓️ June 26
⏰ 13:00, Crystal Room
Speakers: Zaccari Ricci, Raj Basu, Giovanni Ceschia

AKI is common in pediatric kidney, liver and heart transplant patients.

AKI in pediatric solid organ transplant patients is common, affecting 37-57%, depending on the type of transplanted organ. Ask us how BioPorto’s NGAL tests can help you assess AKI risk in these vulnerable patients.
#KidsTransplantWeek #NGAL4kids